Baidu
map
FRONT GENET 润色咨询

Frontiers in Genetics

出版年份:暂无数据 年文章数:9811 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:1.3% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2221839, encodeId=9194222183913, content=偏重的研究方向:肿瘤;基因<br>经验分享:6月27submit 8月3日第一轮审稿意见回来,一共2个审稿人 8月14日修回 8月15日一个审稿人再次提出了一些建议,当天就修回了 8月16日和8月17日2个审稿人陆续endorse 8月21日接收 整个过程挺顺利的,审稿人的审稿意见都很中肯。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0558563830, createdName=ms1000001357370242, createdTime=Thu Aug 22 08:43:43 CST 2024, time=2024-08-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2216376, encodeId=039a22163e6e5, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:植物转录组<br>经验分享:请问大家投Frontier in genetics之前都查重了吗?杂志对重复率的要求是怎么样的呀?请前辈们都来指点迷津, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a459395780, createdName=ms2000001592249343, createdTime=Tue Jul 23 09:02:04 CST 2024, time=2024-07-23, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=1222701, encodeId=fc861222e0150, content=偏重的研究方向:生物信息<br>经验分享:4.16刚投了一个偏重算法的纯生信,副主编一共就请了2个审稿人,审稿人1非常nice直接同意接收,审稿人2的问题比较刁钻,尽力回复了也给拒了。副主编还会请第三位审稿人吗😔😔😔, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220527/f872d11666ad4271be846f74e02b89b7/5532cc15e85e4719abf96a130465c946.jpg, createdBy=2c908142929, createdName=ms1000001205788873, createdTime=Fri May 27 00:11:16 CST 2022, time=2022-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116489, encodeId=b5f72116489b1, content=偏重的研究方向:肿瘤;纯生信;基因<br>经验分享:投了一篇转录因子调控网络图的纯生信,第一个审稿人给了2323,主要要求要我补实验,别的都是统计学小问题,准备补个PCR,希望可以过!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab055420094, createdName=少年宁, createdTime=Sun Feb 26 00:25:27 CST 2023, time=2023-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2203484, encodeId=0d482203484f1, content=This manuscript does not fulfill the standards established for the journal to be considered for publication, and according to Frontiers policies (https://www***ontiersin.org/guidelines/policies-and-publication-ethics#AuthorshipAuthorResponsibilities), the article is being rejected. This decision applies across all Frontiers journals and is final., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8fe96448100, createdName=ms3000000420360328, createdTime=Wed May 08 17:28:10 CST 2024, time=2024-05-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2179183, encodeId=9b4221e9183e1, content=审稿速度:2.0<br>经验分享:经验分享:11月03日投稿,11月06日审稿人1 建议拒稿,11月27日审稿人2 建议Minor revision,11月28日审稿人3建议Major revision,给了2周返修时间,12月10日所有意见返修过去, 12月27日审稿人3 建议拒稿,12月28日,审稿人2 同意发表。各位帮忙分析一下我的文章还有戏吗? 焦虑中......., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=80c66157856, createdName=ms3000000029380120, createdTime=Thu Jan 04 10:11:21 CST 2024, time=2024-01-04, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2145809, encodeId=544b214580929, content=审稿速度:6.0<br>经验分享:太无耻了,开始找的第一个审稿人建议大修,返回已经后是同意录用,后面一直在找别的审稿人,到投稿6个月的时候才找到第二个审稿人。但是奇葩操作来了,在最后一个审稿人没回复的情况下,编辑直接拒稿,我是想问这个杂志社是不是有毛病?拒稿为什么不早点拒稿,耽误别人半年时间,我想请问能不能发邮件喷这个SB编辑,再也不投这个fronter系列杂志了,白白延误别人时间又莫名其妙的拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=024e2688919, createdName=287119938, createdTime=Sat Jul 01 12:35:51 CST 2023, time=2023-07-01, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2143081, encodeId=03f3214308163, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:点突变<br>经验分享:麻烦问下,从接收到正式发表,需要多长时间呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fceb6442587, createdName=ms9000001727788658, createdTime=Fri Jun 16 09:24:12 CST 2023, time=2023-06-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1242528, encodeId=2c241242528ae, content=偏重的研究方向:肿瘤;基因;生信<br>经验分享:合伙搞了篇生信,投稿时需要原始数据,今天上传了,希望编辑和审稿人给过吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7c696163486, createdName=ms8000000941284145, createdTime=Thu Sep 01 18:13:31 CST 2022, time=2022-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100097, encodeId=5140210009e8e, content=偏重的研究方向:纯生信;生信;生物信息<br>经验分享:请问一下纯生信的只给原始数据不上传代码可以吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e795651310, createdName=ms9000000913432311, createdTime=Sat Nov 12 16:13:48 CST 2022, time=2022-11-12, status=1, ipAttribution=)]
    2024-08-22 ms1000001357370242 来自广东省

    偏重的研究方向:肿瘤;基因
    经验分享:6月27submit 8月3日第一轮审稿意见回来,一共2个审稿人 8月14日修回 8月15日一个审稿人再次提出了一些建议,当天就修回了 8月16日和8月17日2个审稿人陆续endorse 8月21日接收 整个过程挺顺利的,审稿人的审稿意见都很中肯。

    2

    展开2条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2221839, encodeId=9194222183913, content=偏重的研究方向:肿瘤;基因<br>经验分享:6月27submit 8月3日第一轮审稿意见回来,一共2个审稿人 8月14日修回 8月15日一个审稿人再次提出了一些建议,当天就修回了 8月16日和8月17日2个审稿人陆续endorse 8月21日接收 整个过程挺顺利的,审稿人的审稿意见都很中肯。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0558563830, createdName=ms1000001357370242, createdTime=Thu Aug 22 08:43:43 CST 2024, time=2024-08-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2216376, encodeId=039a22163e6e5, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:植物转录组<br>经验分享:请问大家投Frontier in genetics之前都查重了吗?杂志对重复率的要求是怎么样的呀?请前辈们都来指点迷津, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a459395780, createdName=ms2000001592249343, createdTime=Tue Jul 23 09:02:04 CST 2024, time=2024-07-23, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=1222701, encodeId=fc861222e0150, content=偏重的研究方向:生物信息<br>经验分享:4.16刚投了一个偏重算法的纯生信,副主编一共就请了2个审稿人,审稿人1非常nice直接同意接收,审稿人2的问题比较刁钻,尽力回复了也给拒了。副主编还会请第三位审稿人吗😔😔😔, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220527/f872d11666ad4271be846f74e02b89b7/5532cc15e85e4719abf96a130465c946.jpg, createdBy=2c908142929, createdName=ms1000001205788873, createdTime=Fri May 27 00:11:16 CST 2022, time=2022-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116489, encodeId=b5f72116489b1, content=偏重的研究方向:肿瘤;纯生信;基因<br>经验分享:投了一篇转录因子调控网络图的纯生信,第一个审稿人给了2323,主要要求要我补实验,别的都是统计学小问题,准备补个PCR,希望可以过!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab055420094, createdName=少年宁, createdTime=Sun Feb 26 00:25:27 CST 2023, time=2023-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2203484, encodeId=0d482203484f1, content=This manuscript does not fulfill the standards established for the journal to be considered for publication, and according to Frontiers policies (https://www***ontiersin.org/guidelines/policies-and-publication-ethics#AuthorshipAuthorResponsibilities), the article is being rejected. This decision applies across all Frontiers journals and is final., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8fe96448100, createdName=ms3000000420360328, createdTime=Wed May 08 17:28:10 CST 2024, time=2024-05-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2179183, encodeId=9b4221e9183e1, content=审稿速度:2.0<br>经验分享:经验分享:11月03日投稿,11月06日审稿人1 建议拒稿,11月27日审稿人2 建议Minor revision,11月28日审稿人3建议Major revision,给了2周返修时间,12月10日所有意见返修过去, 12月27日审稿人3 建议拒稿,12月28日,审稿人2 同意发表。各位帮忙分析一下我的文章还有戏吗? 焦虑中......., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=80c66157856, createdName=ms3000000029380120, createdTime=Thu Jan 04 10:11:21 CST 2024, time=2024-01-04, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2145809, encodeId=544b214580929, content=审稿速度:6.0<br>经验分享:太无耻了,开始找的第一个审稿人建议大修,返回已经后是同意录用,后面一直在找别的审稿人,到投稿6个月的时候才找到第二个审稿人。但是奇葩操作来了,在最后一个审稿人没回复的情况下,编辑直接拒稿,我是想问这个杂志社是不是有毛病?拒稿为什么不早点拒稿,耽误别人半年时间,我想请问能不能发邮件喷这个SB编辑,再也不投这个fronter系列杂志了,白白延误别人时间又莫名其妙的拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=024e2688919, createdName=287119938, createdTime=Sat Jul 01 12:35:51 CST 2023, time=2023-07-01, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2143081, encodeId=03f3214308163, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:点突变<br>经验分享:麻烦问下,从接收到正式发表,需要多长时间呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fceb6442587, createdName=ms9000001727788658, createdTime=Fri Jun 16 09:24:12 CST 2023, time=2023-06-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1242528, encodeId=2c241242528ae, content=偏重的研究方向:肿瘤;基因;生信<br>经验分享:合伙搞了篇生信,投稿时需要原始数据,今天上传了,希望编辑和审稿人给过吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7c696163486, createdName=ms8000000941284145, createdTime=Thu Sep 01 18:13:31 CST 2022, time=2022-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100097, encodeId=5140210009e8e, content=偏重的研究方向:纯生信;生信;生物信息<br>经验分享:请问一下纯生信的只给原始数据不上传代码可以吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e795651310, createdName=ms9000000913432311, createdTime=Sat Nov 12 16:13:48 CST 2022, time=2022-11-12, status=1, ipAttribution=)]
    2024-07-23 ms2000001592249343 来自甘肃省

    审稿速度:3.0 | 投稿命中率:50.0
    偏重的研究方向:植物转录组
    经验分享:请问大家投Frontier in genetics之前都查重了吗?杂志对重复率的要求是怎么样的呀?请前辈们都来指点迷津

    2

    展开2条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2221839, encodeId=9194222183913, content=偏重的研究方向:肿瘤;基因<br>经验分享:6月27submit 8月3日第一轮审稿意见回来,一共2个审稿人 8月14日修回 8月15日一个审稿人再次提出了一些建议,当天就修回了 8月16日和8月17日2个审稿人陆续endorse 8月21日接收 整个过程挺顺利的,审稿人的审稿意见都很中肯。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0558563830, createdName=ms1000001357370242, createdTime=Thu Aug 22 08:43:43 CST 2024, time=2024-08-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2216376, encodeId=039a22163e6e5, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:植物转录组<br>经验分享:请问大家投Frontier in genetics之前都查重了吗?杂志对重复率的要求是怎么样的呀?请前辈们都来指点迷津, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a459395780, createdName=ms2000001592249343, createdTime=Tue Jul 23 09:02:04 CST 2024, time=2024-07-23, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=1222701, encodeId=fc861222e0150, content=偏重的研究方向:生物信息<br>经验分享:4.16刚投了一个偏重算法的纯生信,副主编一共就请了2个审稿人,审稿人1非常nice直接同意接收,审稿人2的问题比较刁钻,尽力回复了也给拒了。副主编还会请第三位审稿人吗😔😔😔, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220527/f872d11666ad4271be846f74e02b89b7/5532cc15e85e4719abf96a130465c946.jpg, createdBy=2c908142929, createdName=ms1000001205788873, createdTime=Fri May 27 00:11:16 CST 2022, time=2022-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116489, encodeId=b5f72116489b1, content=偏重的研究方向:肿瘤;纯生信;基因<br>经验分享:投了一篇转录因子调控网络图的纯生信,第一个审稿人给了2323,主要要求要我补实验,别的都是统计学小问题,准备补个PCR,希望可以过!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab055420094, createdName=少年宁, createdTime=Sun Feb 26 00:25:27 CST 2023, time=2023-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2203484, encodeId=0d482203484f1, content=This manuscript does not fulfill the standards established for the journal to be considered for publication, and according to Frontiers policies (https://www***ontiersin.org/guidelines/policies-and-publication-ethics#AuthorshipAuthorResponsibilities), the article is being rejected. This decision applies across all Frontiers journals and is final., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8fe96448100, createdName=ms3000000420360328, createdTime=Wed May 08 17:28:10 CST 2024, time=2024-05-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2179183, encodeId=9b4221e9183e1, content=审稿速度:2.0<br>经验分享:经验分享:11月03日投稿,11月06日审稿人1 建议拒稿,11月27日审稿人2 建议Minor revision,11月28日审稿人3建议Major revision,给了2周返修时间,12月10日所有意见返修过去, 12月27日审稿人3 建议拒稿,12月28日,审稿人2 同意发表。各位帮忙分析一下我的文章还有戏吗? 焦虑中......., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=80c66157856, createdName=ms3000000029380120, createdTime=Thu Jan 04 10:11:21 CST 2024, time=2024-01-04, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2145809, encodeId=544b214580929, content=审稿速度:6.0<br>经验分享:太无耻了,开始找的第一个审稿人建议大修,返回已经后是同意录用,后面一直在找别的审稿人,到投稿6个月的时候才找到第二个审稿人。但是奇葩操作来了,在最后一个审稿人没回复的情况下,编辑直接拒稿,我是想问这个杂志社是不是有毛病?拒稿为什么不早点拒稿,耽误别人半年时间,我想请问能不能发邮件喷这个SB编辑,再也不投这个fronter系列杂志了,白白延误别人时间又莫名其妙的拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=024e2688919, createdName=287119938, createdTime=Sat Jul 01 12:35:51 CST 2023, time=2023-07-01, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2143081, encodeId=03f3214308163, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:点突变<br>经验分享:麻烦问下,从接收到正式发表,需要多长时间呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fceb6442587, createdName=ms9000001727788658, createdTime=Fri Jun 16 09:24:12 CST 2023, time=2023-06-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1242528, encodeId=2c241242528ae, content=偏重的研究方向:肿瘤;基因;生信<br>经验分享:合伙搞了篇生信,投稿时需要原始数据,今天上传了,希望编辑和审稿人给过吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7c696163486, createdName=ms8000000941284145, createdTime=Thu Sep 01 18:13:31 CST 2022, time=2022-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100097, encodeId=5140210009e8e, content=偏重的研究方向:纯生信;生信;生物信息<br>经验分享:请问一下纯生信的只给原始数据不上传代码可以吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e795651310, createdName=ms9000000913432311, createdTime=Sat Nov 12 16:13:48 CST 2022, time=2022-11-12, status=1, ipAttribution=)]
    2022-05-27 ms1000001205788873

    偏重的研究方向:生物信息
    经验分享:4.16刚投了一个偏重算法的纯生信,副主编一共就请了2个审稿人,审稿人1非常nice直接同意接收,审稿人2的问题比较刁钻,尽力回复了也给拒了。副主编还会请第三位审稿人吗😔😔😔

    9

    展开9条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2221839, encodeId=9194222183913, content=偏重的研究方向:肿瘤;基因<br>经验分享:6月27submit 8月3日第一轮审稿意见回来,一共2个审稿人 8月14日修回 8月15日一个审稿人再次提出了一些建议,当天就修回了 8月16日和8月17日2个审稿人陆续endorse 8月21日接收 整个过程挺顺利的,审稿人的审稿意见都很中肯。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0558563830, createdName=ms1000001357370242, createdTime=Thu Aug 22 08:43:43 CST 2024, time=2024-08-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2216376, encodeId=039a22163e6e5, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:植物转录组<br>经验分享:请问大家投Frontier in genetics之前都查重了吗?杂志对重复率的要求是怎么样的呀?请前辈们都来指点迷津, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a459395780, createdName=ms2000001592249343, createdTime=Tue Jul 23 09:02:04 CST 2024, time=2024-07-23, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=1222701, encodeId=fc861222e0150, content=偏重的研究方向:生物信息<br>经验分享:4.16刚投了一个偏重算法的纯生信,副主编一共就请了2个审稿人,审稿人1非常nice直接同意接收,审稿人2的问题比较刁钻,尽力回复了也给拒了。副主编还会请第三位审稿人吗😔😔😔, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220527/f872d11666ad4271be846f74e02b89b7/5532cc15e85e4719abf96a130465c946.jpg, createdBy=2c908142929, createdName=ms1000001205788873, createdTime=Fri May 27 00:11:16 CST 2022, time=2022-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116489, encodeId=b5f72116489b1, content=偏重的研究方向:肿瘤;纯生信;基因<br>经验分享:投了一篇转录因子调控网络图的纯生信,第一个审稿人给了2323,主要要求要我补实验,别的都是统计学小问题,准备补个PCR,希望可以过!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab055420094, createdName=少年宁, createdTime=Sun Feb 26 00:25:27 CST 2023, time=2023-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2203484, encodeId=0d482203484f1, content=This manuscript does not fulfill the standards established for the journal to be considered for publication, and according to Frontiers policies (https://www***ontiersin.org/guidelines/policies-and-publication-ethics#AuthorshipAuthorResponsibilities), the article is being rejected. This decision applies across all Frontiers journals and is final., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8fe96448100, createdName=ms3000000420360328, createdTime=Wed May 08 17:28:10 CST 2024, time=2024-05-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2179183, encodeId=9b4221e9183e1, content=审稿速度:2.0<br>经验分享:经验分享:11月03日投稿,11月06日审稿人1 建议拒稿,11月27日审稿人2 建议Minor revision,11月28日审稿人3建议Major revision,给了2周返修时间,12月10日所有意见返修过去, 12月27日审稿人3 建议拒稿,12月28日,审稿人2 同意发表。各位帮忙分析一下我的文章还有戏吗? 焦虑中......., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=80c66157856, createdName=ms3000000029380120, createdTime=Thu Jan 04 10:11:21 CST 2024, time=2024-01-04, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2145809, encodeId=544b214580929, content=审稿速度:6.0<br>经验分享:太无耻了,开始找的第一个审稿人建议大修,返回已经后是同意录用,后面一直在找别的审稿人,到投稿6个月的时候才找到第二个审稿人。但是奇葩操作来了,在最后一个审稿人没回复的情况下,编辑直接拒稿,我是想问这个杂志社是不是有毛病?拒稿为什么不早点拒稿,耽误别人半年时间,我想请问能不能发邮件喷这个SB编辑,再也不投这个fronter系列杂志了,白白延误别人时间又莫名其妙的拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=024e2688919, createdName=287119938, createdTime=Sat Jul 01 12:35:51 CST 2023, time=2023-07-01, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2143081, encodeId=03f3214308163, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:点突变<br>经验分享:麻烦问下,从接收到正式发表,需要多长时间呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fceb6442587, createdName=ms9000001727788658, createdTime=Fri Jun 16 09:24:12 CST 2023, time=2023-06-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1242528, encodeId=2c241242528ae, content=偏重的研究方向:肿瘤;基因;生信<br>经验分享:合伙搞了篇生信,投稿时需要原始数据,今天上传了,希望编辑和审稿人给过吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7c696163486, createdName=ms8000000941284145, createdTime=Thu Sep 01 18:13:31 CST 2022, time=2022-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100097, encodeId=5140210009e8e, content=偏重的研究方向:纯生信;生信;生物信息<br>经验分享:请问一下纯生信的只给原始数据不上传代码可以吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e795651310, createdName=ms9000000913432311, createdTime=Sat Nov 12 16:13:48 CST 2022, time=2022-11-12, status=1, ipAttribution=)]
    2023-02-26 少年宁 来自浙江省

    偏重的研究方向:肿瘤;纯生信;基因
    经验分享:投了一篇转录因子调控网络图的纯生信,第一个审稿人给了2323,主要要求要我补实验,别的都是统计学小问题,准备补个PCR,希望可以过!

    8

    展开8条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2221839, encodeId=9194222183913, content=偏重的研究方向:肿瘤;基因<br>经验分享:6月27submit 8月3日第一轮审稿意见回来,一共2个审稿人 8月14日修回 8月15日一个审稿人再次提出了一些建议,当天就修回了 8月16日和8月17日2个审稿人陆续endorse 8月21日接收 整个过程挺顺利的,审稿人的审稿意见都很中肯。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0558563830, createdName=ms1000001357370242, createdTime=Thu Aug 22 08:43:43 CST 2024, time=2024-08-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2216376, encodeId=039a22163e6e5, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:植物转录组<br>经验分享:请问大家投Frontier in genetics之前都查重了吗?杂志对重复率的要求是怎么样的呀?请前辈们都来指点迷津, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a459395780, createdName=ms2000001592249343, createdTime=Tue Jul 23 09:02:04 CST 2024, time=2024-07-23, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=1222701, encodeId=fc861222e0150, content=偏重的研究方向:生物信息<br>经验分享:4.16刚投了一个偏重算法的纯生信,副主编一共就请了2个审稿人,审稿人1非常nice直接同意接收,审稿人2的问题比较刁钻,尽力回复了也给拒了。副主编还会请第三位审稿人吗😔😔😔, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220527/f872d11666ad4271be846f74e02b89b7/5532cc15e85e4719abf96a130465c946.jpg, createdBy=2c908142929, createdName=ms1000001205788873, createdTime=Fri May 27 00:11:16 CST 2022, time=2022-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116489, encodeId=b5f72116489b1, content=偏重的研究方向:肿瘤;纯生信;基因<br>经验分享:投了一篇转录因子调控网络图的纯生信,第一个审稿人给了2323,主要要求要我补实验,别的都是统计学小问题,准备补个PCR,希望可以过!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab055420094, createdName=少年宁, createdTime=Sun Feb 26 00:25:27 CST 2023, time=2023-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2203484, encodeId=0d482203484f1, content=This manuscript does not fulfill the standards established for the journal to be considered for publication, and according to Frontiers policies (https://www***ontiersin.org/guidelines/policies-and-publication-ethics#AuthorshipAuthorResponsibilities), the article is being rejected. This decision applies across all Frontiers journals and is final., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8fe96448100, createdName=ms3000000420360328, createdTime=Wed May 08 17:28:10 CST 2024, time=2024-05-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2179183, encodeId=9b4221e9183e1, content=审稿速度:2.0<br>经验分享:经验分享:11月03日投稿,11月06日审稿人1 建议拒稿,11月27日审稿人2 建议Minor revision,11月28日审稿人3建议Major revision,给了2周返修时间,12月10日所有意见返修过去, 12月27日审稿人3 建议拒稿,12月28日,审稿人2 同意发表。各位帮忙分析一下我的文章还有戏吗? 焦虑中......., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=80c66157856, createdName=ms3000000029380120, createdTime=Thu Jan 04 10:11:21 CST 2024, time=2024-01-04, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2145809, encodeId=544b214580929, content=审稿速度:6.0<br>经验分享:太无耻了,开始找的第一个审稿人建议大修,返回已经后是同意录用,后面一直在找别的审稿人,到投稿6个月的时候才找到第二个审稿人。但是奇葩操作来了,在最后一个审稿人没回复的情况下,编辑直接拒稿,我是想问这个杂志社是不是有毛病?拒稿为什么不早点拒稿,耽误别人半年时间,我想请问能不能发邮件喷这个SB编辑,再也不投这个fronter系列杂志了,白白延误别人时间又莫名其妙的拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=024e2688919, createdName=287119938, createdTime=Sat Jul 01 12:35:51 CST 2023, time=2023-07-01, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2143081, encodeId=03f3214308163, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:点突变<br>经验分享:麻烦问下,从接收到正式发表,需要多长时间呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fceb6442587, createdName=ms9000001727788658, createdTime=Fri Jun 16 09:24:12 CST 2023, time=2023-06-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1242528, encodeId=2c241242528ae, content=偏重的研究方向:肿瘤;基因;生信<br>经验分享:合伙搞了篇生信,投稿时需要原始数据,今天上传了,希望编辑和审稿人给过吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7c696163486, createdName=ms8000000941284145, createdTime=Thu Sep 01 18:13:31 CST 2022, time=2022-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100097, encodeId=5140210009e8e, content=偏重的研究方向:纯生信;生信;生物信息<br>经验分享:请问一下纯生信的只给原始数据不上传代码可以吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e795651310, createdName=ms9000000913432311, createdTime=Sat Nov 12 16:13:48 CST 2022, time=2022-11-12, status=1, ipAttribution=)]
    2024-05-08 ms3000000420360328 来自浙江省

    This manuscript does not fulfill the standards established for the journal to be considered for publication, and according to Frontiers policies (https://www***ontiersin.org/guidelines/policies-and-publication-ethics#AuthorshipAuthorResponsibilities), the article is being rejected. This decision applies across all Frontiers journals and is final.

    1

    展开1条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2221839, encodeId=9194222183913, content=偏重的研究方向:肿瘤;基因<br>经验分享:6月27submit 8月3日第一轮审稿意见回来,一共2个审稿人 8月14日修回 8月15日一个审稿人再次提出了一些建议,当天就修回了 8月16日和8月17日2个审稿人陆续endorse 8月21日接收 整个过程挺顺利的,审稿人的审稿意见都很中肯。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0558563830, createdName=ms1000001357370242, createdTime=Thu Aug 22 08:43:43 CST 2024, time=2024-08-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2216376, encodeId=039a22163e6e5, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:植物转录组<br>经验分享:请问大家投Frontier in genetics之前都查重了吗?杂志对重复率的要求是怎么样的呀?请前辈们都来指点迷津, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a459395780, createdName=ms2000001592249343, createdTime=Tue Jul 23 09:02:04 CST 2024, time=2024-07-23, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=1222701, encodeId=fc861222e0150, content=偏重的研究方向:生物信息<br>经验分享:4.16刚投了一个偏重算法的纯生信,副主编一共就请了2个审稿人,审稿人1非常nice直接同意接收,审稿人2的问题比较刁钻,尽力回复了也给拒了。副主编还会请第三位审稿人吗😔😔😔, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220527/f872d11666ad4271be846f74e02b89b7/5532cc15e85e4719abf96a130465c946.jpg, createdBy=2c908142929, createdName=ms1000001205788873, createdTime=Fri May 27 00:11:16 CST 2022, time=2022-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116489, encodeId=b5f72116489b1, content=偏重的研究方向:肿瘤;纯生信;基因<br>经验分享:投了一篇转录因子调控网络图的纯生信,第一个审稿人给了2323,主要要求要我补实验,别的都是统计学小问题,准备补个PCR,希望可以过!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab055420094, createdName=少年宁, createdTime=Sun Feb 26 00:25:27 CST 2023, time=2023-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2203484, encodeId=0d482203484f1, content=This manuscript does not fulfill the standards established for the journal to be considered for publication, and according to Frontiers policies (https://www***ontiersin.org/guidelines/policies-and-publication-ethics#AuthorshipAuthorResponsibilities), the article is being rejected. This decision applies across all Frontiers journals and is final., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8fe96448100, createdName=ms3000000420360328, createdTime=Wed May 08 17:28:10 CST 2024, time=2024-05-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2179183, encodeId=9b4221e9183e1, content=审稿速度:2.0<br>经验分享:经验分享:11月03日投稿,11月06日审稿人1 建议拒稿,11月27日审稿人2 建议Minor revision,11月28日审稿人3建议Major revision,给了2周返修时间,12月10日所有意见返修过去, 12月27日审稿人3 建议拒稿,12月28日,审稿人2 同意发表。各位帮忙分析一下我的文章还有戏吗? 焦虑中......., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=80c66157856, createdName=ms3000000029380120, createdTime=Thu Jan 04 10:11:21 CST 2024, time=2024-01-04, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2145809, encodeId=544b214580929, content=审稿速度:6.0<br>经验分享:太无耻了,开始找的第一个审稿人建议大修,返回已经后是同意录用,后面一直在找别的审稿人,到投稿6个月的时候才找到第二个审稿人。但是奇葩操作来了,在最后一个审稿人没回复的情况下,编辑直接拒稿,我是想问这个杂志社是不是有毛病?拒稿为什么不早点拒稿,耽误别人半年时间,我想请问能不能发邮件喷这个SB编辑,再也不投这个fronter系列杂志了,白白延误别人时间又莫名其妙的拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=024e2688919, createdName=287119938, createdTime=Sat Jul 01 12:35:51 CST 2023, time=2023-07-01, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2143081, encodeId=03f3214308163, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:点突变<br>经验分享:麻烦问下,从接收到正式发表,需要多长时间呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fceb6442587, createdName=ms9000001727788658, createdTime=Fri Jun 16 09:24:12 CST 2023, time=2023-06-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1242528, encodeId=2c241242528ae, content=偏重的研究方向:肿瘤;基因;生信<br>经验分享:合伙搞了篇生信,投稿时需要原始数据,今天上传了,希望编辑和审稿人给过吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7c696163486, createdName=ms8000000941284145, createdTime=Thu Sep 01 18:13:31 CST 2022, time=2022-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100097, encodeId=5140210009e8e, content=偏重的研究方向:纯生信;生信;生物信息<br>经验分享:请问一下纯生信的只给原始数据不上传代码可以吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e795651310, createdName=ms9000000913432311, createdTime=Sat Nov 12 16:13:48 CST 2022, time=2022-11-12, status=1, ipAttribution=)]
    2024-01-04 ms3000000029380120 来自江苏省

    审稿速度:2.0
    经验分享:经验分享:11月03日投稿,11月06日审稿人1 建议拒稿,11月27日审稿人2 建议Minor revision,11月28日审稿人3建议Major revision,给了2周返修时间,12月10日所有意见返修过去, 12月27日审稿人3 建议拒稿,12月28日,审稿人2 同意发表。各位帮忙分析一下我的文章还有戏吗? 焦虑中.......

    3

    展开3条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2221839, encodeId=9194222183913, content=偏重的研究方向:肿瘤;基因<br>经验分享:6月27submit 8月3日第一轮审稿意见回来,一共2个审稿人 8月14日修回 8月15日一个审稿人再次提出了一些建议,当天就修回了 8月16日和8月17日2个审稿人陆续endorse 8月21日接收 整个过程挺顺利的,审稿人的审稿意见都很中肯。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0558563830, createdName=ms1000001357370242, createdTime=Thu Aug 22 08:43:43 CST 2024, time=2024-08-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2216376, encodeId=039a22163e6e5, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:植物转录组<br>经验分享:请问大家投Frontier in genetics之前都查重了吗?杂志对重复率的要求是怎么样的呀?请前辈们都来指点迷津, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a459395780, createdName=ms2000001592249343, createdTime=Tue Jul 23 09:02:04 CST 2024, time=2024-07-23, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=1222701, encodeId=fc861222e0150, content=偏重的研究方向:生物信息<br>经验分享:4.16刚投了一个偏重算法的纯生信,副主编一共就请了2个审稿人,审稿人1非常nice直接同意接收,审稿人2的问题比较刁钻,尽力回复了也给拒了。副主编还会请第三位审稿人吗😔😔😔, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220527/f872d11666ad4271be846f74e02b89b7/5532cc15e85e4719abf96a130465c946.jpg, createdBy=2c908142929, createdName=ms1000001205788873, createdTime=Fri May 27 00:11:16 CST 2022, time=2022-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116489, encodeId=b5f72116489b1, content=偏重的研究方向:肿瘤;纯生信;基因<br>经验分享:投了一篇转录因子调控网络图的纯生信,第一个审稿人给了2323,主要要求要我补实验,别的都是统计学小问题,准备补个PCR,希望可以过!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab055420094, createdName=少年宁, createdTime=Sun Feb 26 00:25:27 CST 2023, time=2023-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2203484, encodeId=0d482203484f1, content=This manuscript does not fulfill the standards established for the journal to be considered for publication, and according to Frontiers policies (https://www***ontiersin.org/guidelines/policies-and-publication-ethics#AuthorshipAuthorResponsibilities), the article is being rejected. This decision applies across all Frontiers journals and is final., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8fe96448100, createdName=ms3000000420360328, createdTime=Wed May 08 17:28:10 CST 2024, time=2024-05-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2179183, encodeId=9b4221e9183e1, content=审稿速度:2.0<br>经验分享:经验分享:11月03日投稿,11月06日审稿人1 建议拒稿,11月27日审稿人2 建议Minor revision,11月28日审稿人3建议Major revision,给了2周返修时间,12月10日所有意见返修过去, 12月27日审稿人3 建议拒稿,12月28日,审稿人2 同意发表。各位帮忙分析一下我的文章还有戏吗? 焦虑中......., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=80c66157856, createdName=ms3000000029380120, createdTime=Thu Jan 04 10:11:21 CST 2024, time=2024-01-04, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2145809, encodeId=544b214580929, content=审稿速度:6.0<br>经验分享:太无耻了,开始找的第一个审稿人建议大修,返回已经后是同意录用,后面一直在找别的审稿人,到投稿6个月的时候才找到第二个审稿人。但是奇葩操作来了,在最后一个审稿人没回复的情况下,编辑直接拒稿,我是想问这个杂志社是不是有毛病?拒稿为什么不早点拒稿,耽误别人半年时间,我想请问能不能发邮件喷这个SB编辑,再也不投这个fronter系列杂志了,白白延误别人时间又莫名其妙的拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=024e2688919, createdName=287119938, createdTime=Sat Jul 01 12:35:51 CST 2023, time=2023-07-01, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2143081, encodeId=03f3214308163, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:点突变<br>经验分享:麻烦问下,从接收到正式发表,需要多长时间呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fceb6442587, createdName=ms9000001727788658, createdTime=Fri Jun 16 09:24:12 CST 2023, time=2023-06-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1242528, encodeId=2c241242528ae, content=偏重的研究方向:肿瘤;基因;生信<br>经验分享:合伙搞了篇生信,投稿时需要原始数据,今天上传了,希望编辑和审稿人给过吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7c696163486, createdName=ms8000000941284145, createdTime=Thu Sep 01 18:13:31 CST 2022, time=2022-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100097, encodeId=5140210009e8e, content=偏重的研究方向:纯生信;生信;生物信息<br>经验分享:请问一下纯生信的只给原始数据不上传代码可以吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e795651310, createdName=ms9000000913432311, createdTime=Sat Nov 12 16:13:48 CST 2022, time=2022-11-12, status=1, ipAttribution=)]
    2023-07-01 287119938 来自贵州省

    审稿速度:6.0
    经验分享:太无耻了,开始找的第一个审稿人建议大修,返回已经后是同意录用,后面一直在找别的审稿人,到投稿6个月的时候才找到第二个审稿人。但是奇葩操作来了,在最后一个审稿人没回复的情况下,编辑直接拒稿,我是想问这个杂志社是不是有毛病?拒稿为什么不早点拒稿,耽误别人半年时间,我想请问能不能发邮件喷这个SB编辑,再也不投这个fronter系列杂志了,白白延误别人时间又莫名其妙的拒稿。

    3

    展开3条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2221839, encodeId=9194222183913, content=偏重的研究方向:肿瘤;基因<br>经验分享:6月27submit 8月3日第一轮审稿意见回来,一共2个审稿人 8月14日修回 8月15日一个审稿人再次提出了一些建议,当天就修回了 8月16日和8月17日2个审稿人陆续endorse 8月21日接收 整个过程挺顺利的,审稿人的审稿意见都很中肯。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0558563830, createdName=ms1000001357370242, createdTime=Thu Aug 22 08:43:43 CST 2024, time=2024-08-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2216376, encodeId=039a22163e6e5, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:植物转录组<br>经验分享:请问大家投Frontier in genetics之前都查重了吗?杂志对重复率的要求是怎么样的呀?请前辈们都来指点迷津, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a459395780, createdName=ms2000001592249343, createdTime=Tue Jul 23 09:02:04 CST 2024, time=2024-07-23, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=1222701, encodeId=fc861222e0150, content=偏重的研究方向:生物信息<br>经验分享:4.16刚投了一个偏重算法的纯生信,副主编一共就请了2个审稿人,审稿人1非常nice直接同意接收,审稿人2的问题比较刁钻,尽力回复了也给拒了。副主编还会请第三位审稿人吗😔😔😔, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220527/f872d11666ad4271be846f74e02b89b7/5532cc15e85e4719abf96a130465c946.jpg, createdBy=2c908142929, createdName=ms1000001205788873, createdTime=Fri May 27 00:11:16 CST 2022, time=2022-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116489, encodeId=b5f72116489b1, content=偏重的研究方向:肿瘤;纯生信;基因<br>经验分享:投了一篇转录因子调控网络图的纯生信,第一个审稿人给了2323,主要要求要我补实验,别的都是统计学小问题,准备补个PCR,希望可以过!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab055420094, createdName=少年宁, createdTime=Sun Feb 26 00:25:27 CST 2023, time=2023-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2203484, encodeId=0d482203484f1, content=This manuscript does not fulfill the standards established for the journal to be considered for publication, and according to Frontiers policies (https://www***ontiersin.org/guidelines/policies-and-publication-ethics#AuthorshipAuthorResponsibilities), the article is being rejected. This decision applies across all Frontiers journals and is final., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8fe96448100, createdName=ms3000000420360328, createdTime=Wed May 08 17:28:10 CST 2024, time=2024-05-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2179183, encodeId=9b4221e9183e1, content=审稿速度:2.0<br>经验分享:经验分享:11月03日投稿,11月06日审稿人1 建议拒稿,11月27日审稿人2 建议Minor revision,11月28日审稿人3建议Major revision,给了2周返修时间,12月10日所有意见返修过去, 12月27日审稿人3 建议拒稿,12月28日,审稿人2 同意发表。各位帮忙分析一下我的文章还有戏吗? 焦虑中......., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=80c66157856, createdName=ms3000000029380120, createdTime=Thu Jan 04 10:11:21 CST 2024, time=2024-01-04, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2145809, encodeId=544b214580929, content=审稿速度:6.0<br>经验分享:太无耻了,开始找的第一个审稿人建议大修,返回已经后是同意录用,后面一直在找别的审稿人,到投稿6个月的时候才找到第二个审稿人。但是奇葩操作来了,在最后一个审稿人没回复的情况下,编辑直接拒稿,我是想问这个杂志社是不是有毛病?拒稿为什么不早点拒稿,耽误别人半年时间,我想请问能不能发邮件喷这个SB编辑,再也不投这个fronter系列杂志了,白白延误别人时间又莫名其妙的拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=024e2688919, createdName=287119938, createdTime=Sat Jul 01 12:35:51 CST 2023, time=2023-07-01, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2143081, encodeId=03f3214308163, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:点突变<br>经验分享:麻烦问下,从接收到正式发表,需要多长时间呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fceb6442587, createdName=ms9000001727788658, createdTime=Fri Jun 16 09:24:12 CST 2023, time=2023-06-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1242528, encodeId=2c241242528ae, content=偏重的研究方向:肿瘤;基因;生信<br>经验分享:合伙搞了篇生信,投稿时需要原始数据,今天上传了,希望编辑和审稿人给过吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7c696163486, createdName=ms8000000941284145, createdTime=Thu Sep 01 18:13:31 CST 2022, time=2022-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100097, encodeId=5140210009e8e, content=偏重的研究方向:纯生信;生信;生物信息<br>经验分享:请问一下纯生信的只给原始数据不上传代码可以吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e795651310, createdName=ms9000000913432311, createdTime=Sat Nov 12 16:13:48 CST 2022, time=2022-11-12, status=1, ipAttribution=)]
    2023-06-16 ms9000001727788658 来自北京

    审稿速度:2.0 | 投稿命中率:50.0
    偏重的研究方向:点突变
    经验分享:麻烦问下,从接收到正式发表,需要多长时间呀

    2

    展开2条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2221839, encodeId=9194222183913, content=偏重的研究方向:肿瘤;基因<br>经验分享:6月27submit 8月3日第一轮审稿意见回来,一共2个审稿人 8月14日修回 8月15日一个审稿人再次提出了一些建议,当天就修回了 8月16日和8月17日2个审稿人陆续endorse 8月21日接收 整个过程挺顺利的,审稿人的审稿意见都很中肯。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0558563830, createdName=ms1000001357370242, createdTime=Thu Aug 22 08:43:43 CST 2024, time=2024-08-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2216376, encodeId=039a22163e6e5, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:植物转录组<br>经验分享:请问大家投Frontier in genetics之前都查重了吗?杂志对重复率的要求是怎么样的呀?请前辈们都来指点迷津, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a459395780, createdName=ms2000001592249343, createdTime=Tue Jul 23 09:02:04 CST 2024, time=2024-07-23, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=1222701, encodeId=fc861222e0150, content=偏重的研究方向:生物信息<br>经验分享:4.16刚投了一个偏重算法的纯生信,副主编一共就请了2个审稿人,审稿人1非常nice直接同意接收,审稿人2的问题比较刁钻,尽力回复了也给拒了。副主编还会请第三位审稿人吗😔😔😔, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220527/f872d11666ad4271be846f74e02b89b7/5532cc15e85e4719abf96a130465c946.jpg, createdBy=2c908142929, createdName=ms1000001205788873, createdTime=Fri May 27 00:11:16 CST 2022, time=2022-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116489, encodeId=b5f72116489b1, content=偏重的研究方向:肿瘤;纯生信;基因<br>经验分享:投了一篇转录因子调控网络图的纯生信,第一个审稿人给了2323,主要要求要我补实验,别的都是统计学小问题,准备补个PCR,希望可以过!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab055420094, createdName=少年宁, createdTime=Sun Feb 26 00:25:27 CST 2023, time=2023-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2203484, encodeId=0d482203484f1, content=This manuscript does not fulfill the standards established for the journal to be considered for publication, and according to Frontiers policies (https://www***ontiersin.org/guidelines/policies-and-publication-ethics#AuthorshipAuthorResponsibilities), the article is being rejected. This decision applies across all Frontiers journals and is final., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8fe96448100, createdName=ms3000000420360328, createdTime=Wed May 08 17:28:10 CST 2024, time=2024-05-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2179183, encodeId=9b4221e9183e1, content=审稿速度:2.0<br>经验分享:经验分享:11月03日投稿,11月06日审稿人1 建议拒稿,11月27日审稿人2 建议Minor revision,11月28日审稿人3建议Major revision,给了2周返修时间,12月10日所有意见返修过去, 12月27日审稿人3 建议拒稿,12月28日,审稿人2 同意发表。各位帮忙分析一下我的文章还有戏吗? 焦虑中......., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=80c66157856, createdName=ms3000000029380120, createdTime=Thu Jan 04 10:11:21 CST 2024, time=2024-01-04, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2145809, encodeId=544b214580929, content=审稿速度:6.0<br>经验分享:太无耻了,开始找的第一个审稿人建议大修,返回已经后是同意录用,后面一直在找别的审稿人,到投稿6个月的时候才找到第二个审稿人。但是奇葩操作来了,在最后一个审稿人没回复的情况下,编辑直接拒稿,我是想问这个杂志社是不是有毛病?拒稿为什么不早点拒稿,耽误别人半年时间,我想请问能不能发邮件喷这个SB编辑,再也不投这个fronter系列杂志了,白白延误别人时间又莫名其妙的拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=024e2688919, createdName=287119938, createdTime=Sat Jul 01 12:35:51 CST 2023, time=2023-07-01, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2143081, encodeId=03f3214308163, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:点突变<br>经验分享:麻烦问下,从接收到正式发表,需要多长时间呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fceb6442587, createdName=ms9000001727788658, createdTime=Fri Jun 16 09:24:12 CST 2023, time=2023-06-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1242528, encodeId=2c241242528ae, content=偏重的研究方向:肿瘤;基因;生信<br>经验分享:合伙搞了篇生信,投稿时需要原始数据,今天上传了,希望编辑和审稿人给过吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7c696163486, createdName=ms8000000941284145, createdTime=Thu Sep 01 18:13:31 CST 2022, time=2022-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100097, encodeId=5140210009e8e, content=偏重的研究方向:纯生信;生信;生物信息<br>经验分享:请问一下纯生信的只给原始数据不上传代码可以吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e795651310, createdName=ms9000000913432311, createdTime=Sat Nov 12 16:13:48 CST 2022, time=2022-11-12, status=1, ipAttribution=)]
    2022-09-01 ms8000000941284145

    偏重的研究方向:肿瘤;基因;生信
    经验分享:合伙搞了篇生信,投稿时需要原始数据,今天上传了,希望编辑和审稿人给过吧。

    20

    展开20条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2221839, encodeId=9194222183913, content=偏重的研究方向:肿瘤;基因<br>经验分享:6月27submit 8月3日第一轮审稿意见回来,一共2个审稿人 8月14日修回 8月15日一个审稿人再次提出了一些建议,当天就修回了 8月16日和8月17日2个审稿人陆续endorse 8月21日接收 整个过程挺顺利的,审稿人的审稿意见都很中肯。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0558563830, createdName=ms1000001357370242, createdTime=Thu Aug 22 08:43:43 CST 2024, time=2024-08-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2216376, encodeId=039a22163e6e5, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:植物转录组<br>经验分享:请问大家投Frontier in genetics之前都查重了吗?杂志对重复率的要求是怎么样的呀?请前辈们都来指点迷津, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a459395780, createdName=ms2000001592249343, createdTime=Tue Jul 23 09:02:04 CST 2024, time=2024-07-23, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=1222701, encodeId=fc861222e0150, content=偏重的研究方向:生物信息<br>经验分享:4.16刚投了一个偏重算法的纯生信,副主编一共就请了2个审稿人,审稿人1非常nice直接同意接收,审稿人2的问题比较刁钻,尽力回复了也给拒了。副主编还会请第三位审稿人吗😔😔😔, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220527/f872d11666ad4271be846f74e02b89b7/5532cc15e85e4719abf96a130465c946.jpg, createdBy=2c908142929, createdName=ms1000001205788873, createdTime=Fri May 27 00:11:16 CST 2022, time=2022-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116489, encodeId=b5f72116489b1, content=偏重的研究方向:肿瘤;纯生信;基因<br>经验分享:投了一篇转录因子调控网络图的纯生信,第一个审稿人给了2323,主要要求要我补实验,别的都是统计学小问题,准备补个PCR,希望可以过!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab055420094, createdName=少年宁, createdTime=Sun Feb 26 00:25:27 CST 2023, time=2023-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2203484, encodeId=0d482203484f1, content=This manuscript does not fulfill the standards established for the journal to be considered for publication, and according to Frontiers policies (https://www***ontiersin.org/guidelines/policies-and-publication-ethics#AuthorshipAuthorResponsibilities), the article is being rejected. This decision applies across all Frontiers journals and is final., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8fe96448100, createdName=ms3000000420360328, createdTime=Wed May 08 17:28:10 CST 2024, time=2024-05-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2179183, encodeId=9b4221e9183e1, content=审稿速度:2.0<br>经验分享:经验分享:11月03日投稿,11月06日审稿人1 建议拒稿,11月27日审稿人2 建议Minor revision,11月28日审稿人3建议Major revision,给了2周返修时间,12月10日所有意见返修过去, 12月27日审稿人3 建议拒稿,12月28日,审稿人2 同意发表。各位帮忙分析一下我的文章还有戏吗? 焦虑中......., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=80c66157856, createdName=ms3000000029380120, createdTime=Thu Jan 04 10:11:21 CST 2024, time=2024-01-04, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2145809, encodeId=544b214580929, content=审稿速度:6.0<br>经验分享:太无耻了,开始找的第一个审稿人建议大修,返回已经后是同意录用,后面一直在找别的审稿人,到投稿6个月的时候才找到第二个审稿人。但是奇葩操作来了,在最后一个审稿人没回复的情况下,编辑直接拒稿,我是想问这个杂志社是不是有毛病?拒稿为什么不早点拒稿,耽误别人半年时间,我想请问能不能发邮件喷这个SB编辑,再也不投这个fronter系列杂志了,白白延误别人时间又莫名其妙的拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=024e2688919, createdName=287119938, createdTime=Sat Jul 01 12:35:51 CST 2023, time=2023-07-01, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2143081, encodeId=03f3214308163, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:点突变<br>经验分享:麻烦问下,从接收到正式发表,需要多长时间呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fceb6442587, createdName=ms9000001727788658, createdTime=Fri Jun 16 09:24:12 CST 2023, time=2023-06-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1242528, encodeId=2c241242528ae, content=偏重的研究方向:肿瘤;基因;生信<br>经验分享:合伙搞了篇生信,投稿时需要原始数据,今天上传了,希望编辑和审稿人给过吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7c696163486, createdName=ms8000000941284145, createdTime=Thu Sep 01 18:13:31 CST 2022, time=2022-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100097, encodeId=5140210009e8e, content=偏重的研究方向:纯生信;生信;生物信息<br>经验分享:请问一下纯生信的只给原始数据不上传代码可以吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e795651310, createdName=ms9000000913432311, createdTime=Sat Nov 12 16:13:48 CST 2022, time=2022-11-12, status=1, ipAttribution=)]
    2022-11-12 ms9000000913432311

    偏重的研究方向:纯生信;生信;生物信息
    经验分享:请问一下纯生信的只给原始数据不上传代码可以吗?

    1

    展开1条回复
共500条页码: 1/50页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分

Baidu
Baidu
map
Baidu
map
Baidu
map